Research programme: antiviral therapy : AbbVie/The Scripps Research Institue
Latest Information Update: 06 Apr 2022
At a glance
- Originator The Scripps Research Institute
- Developer AbbVie; The Scripps Research Institute
- Class Antivirals
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research COVID 2019 infections